Page 28 - NAMAH-Apr-2018
P. 28

Namah                                    Vol. 26, Issue 1, 24th April 2018





           2891-11-79.[PMC free article] [PubMed] [Cross Ref].  M, Gachon F, Planchat E, Abrial C, Mouret-
                                                    Reynier MA, Durando X, Barthomeuf C, Chollet
        11.  Marcus A, Craze R. The Herb and Spice Companion.   P. Phase I dose escalation trial of docetaxel
           London: Quantum Publishing; 2000, p. 83.  plus curcumin in patients with advanced and
                                                    metastatic breast cancer.CancerBiolTher Jan
        12.  Alschuler L, ND. Turmeric (Curcuma longa)   2010; 9(1):8-14. Epub 2010 Jan 21.
           An Overview of the Research and Clinical
           Indications; a white paper shared at the NANP   18.  Kuttan R, Sudheeran PC, Joseph CD. Turmeric
           conference, May 2017, at Portland, OR.   and curcumin as topical agents in cancer
                                                    therapy.  Tumori. Feb 28 1987; 73(1): 29-31.
        13.  Hallman K, Aleck K, Dwyer B, Lloyd V, Quigley
           M, Sitto N, Siebert AE, Dinda S. The effects   19.  Quispe-Soto ET, Calaf GM. Effect of curcumin
           of turmeric (curcumin) on tumor suppressor   and paclitaxel on breast carcinogenesis. Int J
           protein (p53) and estrogen receptor (ER) in   Oncol. Dec 2016; 49(6): 2569-77 doi: 10.3892/
           breast cancer cells 2017 Breast Cancer (Dove   ijo.2016.3741. Epub 2016 Oct 19.
           Med Press). 2017 Mar 10; 9:153-161. doi:
           10.2147/BCTT.S125783. eCollection 2017.   20.  Ryan JL, Heckler CE, Ling M, Katz A, Williams
                                                    JP, Pentland AP, Morrow GR. Curcumin for
        14.  Ali NM, Yeap SK, Abu N, Lim KL, Ky H, Pauzi   radiation dermatitis: a randomized, double-
           AZM, Ho WY, Tan SW, Alan-Ong HK, Zareen   blind, placebo-controlled clinical trial of thirty
           S, Alitheen NB, Akhtar MN. Cancer Cell Int. Feb   breast cancer patients. Radiat Res. Jul 2013; 180(1):
           21 2017; 17: 30. doi: 10.1186/s12935-017-  34-43doi: 10.1667/RR3255.1. Epub 2013 Jun 7.
           0400-3. eCollection 2017. Synthetic curcumin
           derivative DK1 possessed G2/M arrest and   21. He ZY, Shi CB, Wen H, Li FL, Wang BL, Wang
           induced apoptosis through accumulation of   J.Upregulation of p53 expression in patients
           intracellular ROS in MCF-7 breast cancer cells.  with colorectal cancer by administration of
                                                    curcumin.
        15.   Khosropanah MH, Dinarvand A, Nezhadhosseini
           A, Haghighi A, Hashemi S, Nirouzad F, Khatamsaz   22. Polasa K, Raghuram TC, Krishna TP,
           S, Entezari M, Hashemi M, Dehghani H. Analysis   Krishnaswamy K. Effect of turmeric on urinary
           of the Antiproliferative Effects of Curcumin and   mutagens in Mills S, Bone K. Principles and
           Nanocurcumin in MDA-MB231 as a Breast Cancer   Practice of Phytotherapy. Toronto, ON: Churchill
           Cell Line.Iran J Pharm Res. Winter 2016; 15(1): 231-9.   Livingstone; 2000.

        16. Saab MB, Estephan E, Bec N, Larroque   23. Golombick T, Diamond TH, Manoharan
           M, Aulombard R, Cloitre T, Gergely CJ. Multi-  A, Ramakrishna R. Monoclonal gammopathy of
           microscopic study of curcumin effect on fixed non-  undetermined significance, smoldering multiple
           malignant and cancerous mammalian epithelial   myeloma, and curcumin: a randomized, double-
           cells. Biophotonics Aug 2011; 4(7-8): 533-43. doi:   blind placebo-controlled cross-over 4g. study and
           10.1002/jbio.201000119. Epub 2011 Mar 10.  an open-label 8g. extension study. Am J Hematol.
                                                    May 2012; 87(5): 455-60. doi: 10.1002/ajh.23159.
        17. Bayet-Robert M, Kwiatkowski F, Leheurteur   Epub 2012 Apr 4.


        28
   23   24   25   26   27   28   29   30   31   32   33